Skip to main content

Advertisement

Log in

Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Cohen TJ, Lee VMY, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17:659–667

    Article  PubMed  CAS  Google Scholar 

  2. Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, Langstom B, Kilander L (2008) In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 35:100–106

    Article  PubMed  Google Scholar 

  3. Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, Liu J, Zhang D, Buratti E, Baralle FE, Bigio EH, Mesulam M, Xu Q, Shen Y, Fushimi K, Wu JY (2011) An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxocity. Nat Struct Mol Biol 18:822–830

    Article  PubMed  CAS  Google Scholar 

  4. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 55:306–319

    Article  PubMed  CAS  Google Scholar 

  5. Lee EB, Lee VM-Y, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nature 13:38–50

    CAS  Google Scholar 

  6. Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, Lee VM-Y, Trojanowski JQ (2013) TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol 125:121–131. doi:10.1007/s00401-012-1055-8

    Article  PubMed  CAS  Google Scholar 

  7. Westermark GT, Johnson KH, Westermark P (1999) Staining methods for identification of amyloid in tissue. Methods Enzymol 309:3–25

    Article  PubMed  CAS  Google Scholar 

  8. Wolozin B (2012) Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener 7:56. doi:10.1186/1750-1326-7-56

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Support from the following is acknowledged: EHB, MM, CG, RG, and MP, NIA AG 13854; JYW, NIA (RO1AG033004), NINDS (R56NS074763) and ALS Therapy Alliance. H-XD, NIH NS078287, NS081474, NS074366; TS, NS078504, NS082104.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eileen H. Bigio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bigio, E.H., Wu, J.Y., Deng, HX. et al. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol 125, 463–465 (2013). https://doi.org/10.1007/s00401-013-1089-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-013-1089-6

Keywords

Navigation